# Olema Pharmaceuticals, Inc.: Form 8-K, filed Nov 19, 2025

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: 8-K
- Filed: 2025-11-19
- Accepted by EDGAR: Nov 19, 2025, 17:20 ET
- Period: 2025-11-19
- Accession: 0001193125-25-288343
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000119312525288343/d46182d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000119312525288343/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000119312525288343/d46182d8k.htm

Filed Nov 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-288343. Last ingested by Listed: Nov 10, 2026, 16:50 ET. No prices; not investment advice.